Field | Row 1 |
---|---|
adsh | 0001558370-25-007765 |
cik | 921114 |
name | ARMATA PHARMACEUTICALS, INC. |
sic | 2836 |
countryba | US |
stprba | CA |
cityba | LOS ANGELES |
zipba | 90066 |
bas1 | 5005 MCCONNELL AVE |
bas2 | |
baph | 310-665-2928 |
countryma | US |
stprma | CA |
cityma | LOS ANGELES |
zipma | 90066 |
mas1 | 5005 MCCONNELL AVE |
mas2 | |
countryinc | US |
stprinc | WA |
ein | 911549568 |
former | AMPLIPHI BIOSCIENCES CORP |
changed | 20130222 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250514 |
accepted | 2025-05-14 16:23:00.0 |
prevrpt | 0 |
detail | 1 |
instance | armp-20250331x10q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001558370-25-007765 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 781000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Accounts Payable And Accrued Liabilities Current | 2055000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1488000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Increase Decrease In Operating Lease Liability | -250000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Intangible Assets Net Excluding Goodwill | 10256000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Liabilities Fair Value Adjustment | 5203000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Net Cash Provided By Used In Investing Activities | -250000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Net Income Loss | -6531000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Net Income Loss | -6531000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20240331 | Operating Expenses | 11194000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Operating Income Loss | -10228000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Operating Lease Liability Current | 4431000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Other Assets Current | 744000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Nonoperating Expense | 3602000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Other Nonoperating Income | 52000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 14000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Payments To Acquire Property Plant And Equipment | 250000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Prepaid Expense And Other Assets Current | 1240000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Proceeds From Issuance Of Secured Debt | 34889000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Profit Loss | -6531000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 5429000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Restricted Stock Shares Issued Net Of Shares For Tax Withholdings | 10412.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20241231 | Retained Earnings Accumulated Deficit | -327735000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Stockholders Equity | 279354000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20241231 | Additional Paid In Capital | 279354000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 534000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 534000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 781000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20250331 | Assets | 87250000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 43340000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 17078000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Convertible Debt Current | 27694000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Earnings Per Share Diluted | -0.6900 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | General And Administrative Expense | 3178000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | General And Administrative Expense | 3178000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20241231 | Liabilities | 134456000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Long Term Debt Current Maturities Other Than Convertible Debt Current | 38954000.0000 | USD | 0 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20250331 | Net Cash Provided By Used In Financing Activities | 9986000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Operating Income Loss | -10228000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Other Nonoperating Income Expense | 1660000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Payments To Acquire Property Plant And Equipment | 99000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 5429000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Restricted Stock Returned Shares Issued Net Of Tax Withholdings | 4222.0000 | shares | 1 | 0001558370-25-007765 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20250331 | Restricted Stock Value Shares Issued Net Of Tax Withholdings | -14000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Restricted Stock Value Shares Issued Net Of Tax Withholdings | -14000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20240331 | Revenue Not From Contract With Customer | 966000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Revenue Not From Contract With Customer | 966000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20241231 | Secured Long Term Debt | 22539000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Stockholders Equity | -56510000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001558370-25-007765 | 20241231 | Common Stock Shares Authorized | 217000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Deferred Income Tax Liabilities Net | 3077000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Earnings Per Share Basic | -0.1800 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Increase Decrease Fair Value Of Liabilities | 13025000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20240331 | Increase Decrease In Deferred Compensation | 180000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -539000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Net Cash Provided By Used In Financing Activities | 34931000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Net Income Loss | -25021000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Operating Income Loss | -8191000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Assets Noncurrent | 975000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Noncash Expense | 3596000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Other Nonoperating Income Expense | -14793000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Proceeds From Exercise Of Warrants And Stock Options | 42000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20250331 | Shares Outstanding | 36193479.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20241231 | Stockholders Equity | -48019000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 36124980.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Assets | 86437000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Cash And Cash Equivalents At Carrying Value | 9291000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Cash And Cash Equivalents At Carrying Value | 11688000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Depreciation Depletion And Amortization | 377000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | General And Administrative Expense | 3253000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Goodwill | 3490000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Increase Decrease In Operating Lease Right Of Use Asset | -464000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20241231 | Liabilities Current | 48249000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Liabilities Fair Value Adjustment | -13025000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Net Cash Provided By Used In Investing Activities | -99000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Net Income Loss | -6531000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20240331 | Noncash Interest Income | 26000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20240331 | Other Noncash Expense | 1815000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Nonoperating Income | 59000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Property Plant And Equipment Net | 12883000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Retained Earnings Accumulated Deficit | -334266000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Stockholders Equity | 361000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20250331 | Stockholders Equity | 362000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 13407.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20250331 | Additional Paid In Capital | 280121000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Assets Current | 13166000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Common Stock Shares Authorized | 217000000.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Common Stock Shares Issued | 36193479.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Common Stock Shares Outstanding | 36183067.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Deferred Income Tax Liabilities Net | 3077000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Depreciation Depletion And Amortization | 317000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | General And Administrative Expense | 3253000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Liabilities And Stockholders Equity | 86437000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Long Term Debt Current Maturities Other Than Convertible Debt Current | 75089000.0000 | USD | 0 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20240331 | Net Cash Provided By Used In Operating Activities | -10584000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Operating Lease Liability Current | 4459000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Other Assets Noncurrent | 975000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Other Liabilities Current | 529000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Revenue Not From Contract With Customer | 491000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Revenue Not From Contract With Customer | 491000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20241231 | Shares Outstanding | 36183067.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20231231 | Stockholders Equity | -32065000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20231231 | Stockholders Equity | 276393000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20231231 | Stockholders Equity | 361000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 19243000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Liabilities Current | 337000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Profit Loss | -25021000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Assets Current | 11308000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Cash And Cash Equivalents At Carrying Value | 37860000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Common Stock Shares Issued | 36183067.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Common Stock Value | 362000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Contribution Of Property | 9000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 26000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Deferred Compensation Liability Current | 1347000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Earnings Per Share Basic | -0.6900 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -553000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Increase Decrease In Operating Lease Liability | -2181000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Increase Decrease In Operating Lease Right Of Use Asset | -597000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1797000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Liabilities Current | 110540000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Net Income Loss | -25021000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Operating Expenses | 11194000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Operating Expenses | 8682000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Operating Income Loss | -8191000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Other Assets Current | 238000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Share Based Compensation | 781000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20231231 | Shares Outstanding | 36122932.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20231231 | Stockholders Equity | -308819000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20250331 | Stockholders Equity | -53783000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 42000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 42000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20250331 | Net Cash Provided By Used In Operating Activities | -7580000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Liabilities And Stockholders Equity | 87250000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Accounts Payable And Accrued Liabilities Current | 1614000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 24097000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 2307000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001558370-25-007765 | 20250331 | Common Stock Shares Outstanding | 36193479.0000 | shares | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Earnings Per Share Diluted | -0.2000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Goodwill | 3490000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Intangible Assets Net Excluding Goodwill | 10256000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Operating Lease Liability Noncurrent | 27694000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Operating Lease Liability Noncurrent | 27416000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Other Nonoperating Expense | 1820000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Other Nonoperating Income Expense | 1660000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20241231 | Prepaid Expense And Other Assets Current | 1273000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Property Plant And Equipment Net | 13241000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 8016000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 8016000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Restricted Cash Noncurrent | 5390000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Stockholders Equity | -333840000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20241231 | Stockholders Equity | 362000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20241231 | Stockholders Equity | -327735000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20250331 | Stockholders Equity | -334266000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 36184802.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 14771000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Common Stock Value | 362000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Contribution Of Property | 425000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Convertible Debt Noncurrent | 32897000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Deferred Compensation Liability Current | 2280000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Increase Decrease Fair Value Of Liabilities | 31400000.0000 | USD | 4 | 0001558370-25-007765 | Counterparty Name= Innoviva Strategic Opportunities Llc; Debt Instrument= Secured Term Loan; | ||
0001558370-25-007765 | 20250331 | Increase Decrease Fair Value Of Liabilities | -5203000.0000 | USD | 1 | 0001558370-25-007765 | |||
0001558370-25-007765 | 20250331 | Increase Decrease In Deferred Compensation | -933000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Liabilities | 141033000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Net Income Loss | -25021000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001558370-25-007765 | 20250331 | Operating Expenses | 8682000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20241231 | Operating Lease Right Of Use Asset | 41687000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Operating Lease Right Of Use Asset | 41090000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Other Nonoperating Income Expense | -14793000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Single Reportable Segment; | ||
0001558370-25-007765 | 20250331 | Proceeds From Issuance Of Secured Debt | 10000000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20250331 | Property Plant And Equipment Net | 12900000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Single Reportable Segment; Geographical= U S; | ||
0001558370-25-007765 | 20240331 | Restricted Cash Noncurrent | 5480000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20241231 | Restricted Cash Noncurrent | 5480000.0000 | USD | 0 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Share Based Compensation | 534000.0000 | USD | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Shares Outstanding | 36132117.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001558370-25-007765 | 20240331 | Stockholders Equity | 276969000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20250331 | Stockholders Equity | 280121000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001558370-25-007765 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 59478662.0000 | shares | 1 | us-gaap/2024 | |||
0001558370-25-007765 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 36124980.0000 | shares | 1 | us-gaap/2024 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Other Nonoperating Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. |
Restricted Stock Returned Shares Issued Net Of Tax Withholdings | 0001558370-25-007765 | 1 | 0 | shares | D | Restricted Stock Returned Shares Issued Net Of Tax Withholdings | Restricted stock returned shares issued net of tax withholdings. | |
Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Secured Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | I | C | Secured Long-Term Debt, Noncurrent | Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets. |
Noncash Interest Income | 0001558370-25-007765 | 1 | 0 | monetary | D | C | Noncash Interest Income | Amount of interest income included in net income that result in no cash inflow |
Increase Decrease In Deferred Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Compensation | The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future. |
Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
Deferred Compensation Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Compensation Liability, Current | Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Other Noncash Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Convertible Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Debt, Noncurrent | Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Convertible Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Debt, Current | The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Revenue Not From Contract With Customer | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue Not from Contract with Customer | Amount of revenue that is not accounted for under Topic 606. |
Increase Decrease Fair Value Of Liabilities | 0001558370-25-007765 | 1 | 0 | monetary | D | D | Increase Decrease Fair Value of Liabilities | Increase (decrease) fair value of liabilities. |
Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense (Excluding Acquired in Process Cost) | Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Long Term Debt Current Maturities Other Than Convertible Debt Current | 0001558370-25-007765 | 1 | 0 | monetary | I | C | Long-Term Debt, Current Maturities Other Than Convertible Debt Current | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation and current convertible debt. |
Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Contribution Of Property | us-gaap/2024 | 0 | 0 | monetary | D | D | Contribution of Property | Value of property contributed in noncash investing and financing activities. |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2024 | 0 | 0 | monetary | D | D | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
Other Nonoperating Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Nonoperating Expense | Amount of expense related to nonoperating activities, classified as other. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
Restricted Stock Value Shares Issued Net Of Tax Withholdings | us-gaap/2024 | 0 | 0 | monetary | D | C | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Proceeds From Exercise Of Warrants And Stock Options | 0001558370-25-007765 | 1 | 0 | monetary | D | D | Proceeds From Exercise Of Warrants And Stock Options | Proceeds from exercise of warrants and stock options. |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Deferred Income Tax Liabilities Net | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Liabilities Fair Value Adjustment | us-gaap/2024 | 0 | 0 | monetary | D | C | Liabilities, Fair Value Adjustment | Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties. |
Restricted Stock Shares Issued Net Of Shares For Tax Withholdings | us-gaap/2024 | 0 | 0 | shares | D | Restricted Stock, Shares Issued Net of Shares for Tax Withholdings | Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. | |
Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Increase Decrease In Operating Lease Right Of Use Asset | 0001558370-25-007765 | 1 | 0 | monetary | D | C | Increase (Decrease) in Operating Lease Right Of Use Asset | The amount of increase (decrease) in operating lease right of use asset. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Proceeds From Issuance Of Secured Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Secured Debt | The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001558370-25-007765 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001558370-25-007765 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
0001558370-25-007765 | 2 | 5 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Other receivables | 0 |
0001558370-25-007765 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001558370-25-007765 | 2 | 7 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
0001558370-25-007765 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0001558370-25-007765 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset | 0 |
0001558370-25-007765 | 2 | 10 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | In-process research and development | 0 |
0001558370-25-007765 | 2 | 11 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
0001558370-25-007765 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
0001558370-25-007765 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0001558370-25-007765 | 2 | 16 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
0001558370-25-007765 | 2 | 17 | BS | 0 | H | Deferred Compensation Liability Current | us-gaap/2024 | Accrued compensation | 0 |
0001558370-25-007765 | 2 | 18 | BS | 0 | H | Convertible Debt Current | us-gaap/2024 | Convertible debt, current | 0 |
0001558370-25-007765 | 2 | 19 | BS | 0 | H | Long Term Debt Current Maturities Other Than Convertible Debt Current | 0001558370-25-007765 | Term debt, current | 0 |
0001558370-25-007765 | 2 | 20 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liabilities | 0 |
0001558370-25-007765 | 2 | 21 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
0001558370-25-007765 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001558370-25-007765 | 2 | 23 | BS | 0 | H | Convertible Debt Noncurrent | us-gaap/2024 | Convertible Loan, non-current | 0 |
0001558370-25-007765 | 2 | 24 | BS | 0 | H | Secured Long Term Debt | us-gaap/2024 | Term debt, non-current | 0 |
0001558370-25-007765 | 2 | 25 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
0001558370-25-007765 | 2 | 26 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2024 | Deferred tax liability | 0 |
0001558370-25-007765 | 2 | 27 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0001558370-25-007765 | 2 | 28 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 12) | 0 |
0001558370-25-007765 | 2 | 30 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,193,479 and 36,183,067 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
0001558370-25-007765 | 2 | 31 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
0001558370-25-007765 | 2 | 32 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0001558370-25-007765 | 2 | 33 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' deficit | 0 |
0001558370-25-007765 | 2 | 34 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' deficit | 0 |
0001558370-25-007765 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
0001558370-25-007765 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0001558370-25-007765 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0001558370-25-007765 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0001558370-25-007765 | 4 | 1 | IS | 0 | H | Revenue Not From Contract With Customer | us-gaap/2024 | Grant revenue | 0 |
0001558370-25-007765 | 4 | 3 | IS | 0 | H | Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | Research and development | 0 |
0001558370-25-007765 | 4 | 4 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
0001558370-25-007765 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
0001558370-25-007765 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
0001558370-25-007765 | 4 | 8 | IS | 0 | H | Other Nonoperating Income | us-gaap/2024 | Interest income | 0 |
0001558370-25-007765 | 4 | 9 | IS | 0 | H | Other Nonoperating Expense | us-gaap/2024 | Interest expense | 1 |
0001558370-25-007765 | 4 | 10 | IS | 0 | H | Liabilities Fair Value Adjustment | us-gaap/2024 | Change in fair value of the Convertible Loan | 0 |
0001558370-25-007765 | 4 | 12 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
0001558370-25-007765 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007765 | 4 | 15 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
0001558370-25-007765 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding, basic | 0 |
0001558370-25-007765 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
0001558370-25-007765 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding, diluted | 0 |
0001558370-25-007765 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balances | 0 |
0001558370-25-007765 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balances (in shares) | 0 |
0001558370-25-007765 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
0001558370-25-007765 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
0001558370-25-007765 | 5 | 13 | EQ | 0 | H | Restricted Stock Returned Shares Issued Net Of Tax Withholdings | 0001558370-25-007765 | Withholdings for taxes related to net share settlement of equity awards, shares | 1 |
0001558370-25-007765 | 5 | 14 | EQ | 0 | H | Restricted Stock Value Shares Issued Net Of Tax Withholdings | us-gaap/2024 | Issuance of common stock upon release of restricted stock units, net of tax withholdings | 0 |
0001558370-25-007765 | 5 | 15 | EQ | 0 | H | Restricted Stock Shares Issued Net Of Shares For Tax Withholdings | us-gaap/2024 | Issuance of common stock upon release of restricted stock units, net of tax withholdings (In shares) | 0 |
0001558370-25-007765 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
0001558370-25-007765 | 5 | 17 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007765 | 5 | 18 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balances | 0 |
0001558370-25-007765 | 5 | 19 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balances (in shares) | 0 |
0001558370-25-007765 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
0001558370-25-007765 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization expense | 0 |
0001558370-25-007765 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
0001558370-25-007765 | 6 | 6 | CF | 0 | H | Increase Decrease Fair Value Of Liabilities | 0001558370-25-007765 | Change in fair value of the Convertible Loan | 0 |
0001558370-25-007765 | 6 | 7 | CF | 0 | H | Other Noncash Expense | us-gaap/2024 | Non-cash interest expense | 0 |
0001558370-25-007765 | 6 | 8 | CF | 0 | H | Noncash Interest Income | 0001558370-25-007765 | Non-cash interest income | 1 |
0001558370-25-007765 | 6 | 10 | CF | 0 | H | Increase Decrease In Operating Lease Right Of Use Asset | 0001558370-25-007765 | Change in right-of-use asset | 1 |
0001558370-25-007765 | 6 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
0001558370-25-007765 | 6 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
0001558370-25-007765 | 6 | 14 | CF | 0 | H | Increase Decrease In Deferred Compensation | us-gaap/2024 | Accrued compensation | 0 |
0001558370-25-007765 | 6 | 15 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
0001558370-25-007765 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
0001558370-25-007765 | 6 | 18 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
0001558370-25-007765 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
0001558370-25-007765 | 6 | 21 | CF | 0 | H | Proceeds From Issuance Of Secured Debt | us-gaap/2024 | Proceeds from issuance of term debt, net of issuance costs | 0 |
0001558370-25-007765 | 6 | 22 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Payments for taxes related to net share settlement of equity awards | 1 |
0001558370-25-007765 | 6 | 23 | CF | 0 | H | Proceeds From Exercise Of Warrants And Stock Options | 0001558370-25-007765 | Proceeds from exercise of stock options | 0 |
0001558370-25-007765 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
0001558370-25-007765 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase in cash, cash equivalents and restricted cash | 0 |
0001558370-25-007765 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash, beginning of period | 0 |
0001558370-25-007765 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash, end of period | 0 |
0001558370-25-007765 | 6 | 29 | CF | 0 | H | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2024 | Unpaid debt issuance costs | 0 |
0001558370-25-007765 | 6 | 30 | CF | 0 | H | Contribution Of Property | us-gaap/2024 | Property and equipment included in accounts payable and accrued liabilities | 0 |
0001558370-25-007765 | 7 | 2 | CF | 1 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001558370-25-007765 | 7 | 3 | CF | 1 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
0001558370-25-007765 | 7 | 4 | CF | 1 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |